16 May 2016
A randomised, double-blind, controlled trial of sitagliptin showed that the diabetes medication works no better than a pacebo in treating nonalcoholic fatty liver disease.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024